Home Overview Press Room Blog Publications For Students about us
Search

Biotech & Pharma : Displaying 759-768 of 1029


Editorial: Cellular mutationSacramento BeeJune 2nd, 2006"In her latest effort to reform California's $3 billion stem cell research institute, state Sen. Deborah Ortiz, D-Sacramento, has introduced SB 401, a proposed ballot measure that seeks to close gaps in Proposition 71..."
Editorial: Legal delays may be a plus for state's stem-cell effortSan Jose Mercury NewsJune 1st, 2006"But the delay has had the side benefit of allowing the stem-cell agency to solidify its planning, structure and regulations."
Cloning Scientist Is Indicted in South Koreaby CHOE SANG-HUNNew York TimesMay 12th, 2006" Hwang Woo Suk, the disgraced cloning expert, was indicted on fraud and embezzlement charges today, months after an investigative panel determined that he had fabricated evidence to prove that he had cloned human cells. "
Stem-cell Research Blasted from New Angle[Quotes CGS's Marcy Darnovsky]by Michelle ChenThe New StandardMay 8th, 2006"Groups that support stem-cell research are warning that the state_s massive research-funding plan is not immune to narrow interest groups that could undermine the potential public-health benefits."
Editorial: Oversight at Pitt: Whither due diligence?Pittsburgh Tribune-ReviewApril 26th, 2006"Schatten may have believed all was well until it became impossible to say so with a straight face. But due diligence by Pitt quite likely would have unraveled the fraud earlier -- perhaps before publication."
Lax oversight by Pitt enabled Schatten fiascoby By Jennifer Bails and Luis FabregasPittsburgh Tribune-ReviewApril 23rd, 2006"The University of Pittsburgh's lax policies and disregard for federal guidelines allowed biologist Gerald Schatten to participate in one of the biggest scientific frauds in history, according to a Pittsburgh Tribune-Review examination. "
A booming baby businessby Evan PondelLA Daily NewsApril 23rd, 2006"The assisted reproductive industry is entirely unregulated. And self-regulation from these companies is inadequate," said Reynolds, director of the project on biotechnology accountability.
Stem cell funding proves elusiveby Terri SomersSan Diego Union TribuneApril 16th, 2006"Despite the hype and debate about stem cell research, there are very few stem cell-based therapies and therefore very few companies based on the science."
Editorial: For $10,000, you get ...Sacramento BeeApril 16th, 2006"Frustrated by lawsuits that have held up funding for California's $3 billion stem cell research institute, some of San Francisco's most prominent philanthropists are holding a gala fundraiser for this state agency on May 22."
Opinion: The legal lock on stem cellsby Jennifer WashburnLos Angeles TimesApril 12th, 2006"CALIFORNIA'S $3-billion stem cell program has encountered repeated setbacks since it was approved by voters 17 months ago. Now it faces an entirely new and potentially even more worrisome challenge arising from two powerful patents..."
Displaying 759-768 of 1029  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760